Impact · Healthcare · Economy · Sovereignty
Faster Diagnosis.
Fewer Deaths.
More Jobs. A Stronger Nigeria.
Local production of diagnostic tests is not just an industrial achievement. It is a public health intervention. Every kit manufactured in Abuja is one less kit that Nigeria has to beg, borrow, or overpay for from abroad.
Nigeria carries one of the
heaviest disease burdens on earth.
These are not statistics. These are the reasons this factory had to be built. Every number below represents real people waiting too long for a diagnosis, or never getting one at all.
Malaria Cases Per Year
Nigeria recorded approximately 58 million malaria cases in 2021, more than any other country in the world. West Africa's share of global malaria deaths is 94%. Rapid diagnostic testing at the point of care is the fastest path to treatment.
Nigerians Living with HIV
Nigeria has the second-largest HIV epidemic in the world, with approximately 1.9 million adults and children living with HIV in 2021. HIV prevalence in West and Central Africa is approximately 1.5%. Access to affordable self-testing kits is critical for early detection and reduced transmission.
Tuberculosis Cases Per Year
Nigeria recorded approximately 288,258 tuberculosis cases in 2021. TB is the leading infectious disease killer globally, and Nigeria remains among the 30 high-burden countries. Rapid diagnostics cut the time between exposure, diagnosis, and treatment initiation.
Highest Maternal Mortality in Africa
Nigeria's maternal mortality rate exceeds 900 deaths per 100,000 live births. Malaria is a significant contributor, complicating pregnancies and leading to preterm births, anaemia, and maternal death. Faster malaria diagnosis in antenatal care settings saves mothers' lives.
What happens when your
supply chain is
someone else's problem.
During the COVID-19 pandemic, the world witnessed what happens when countries with no local diagnostic manufacturing capacity face a global health emergency: supply chains collapsed, prices surged, and nations that could not produce their own tests were left without them.
Nigeria cannot afford to be in that position again. Local production means:
-
Outbreak readiness. When a new pathogen emerges, Nigeria can produce and deploy targeted diagnostic kits within weeks rather than months.
-
Price control. Removing the import premium makes diagnostics affordable for rural health centres, community pharmacies, and individuals who previously could not access them.
-
Supply security. No more dependence on shipping delays, global shortages, or political disruptions to foreign supply chains.
-
Export potential. Nigeria becomes a net exporter of diagnostic capacity to the rest of West Africa and beyond, inverting the historical dependency.
ECOWAS Reach
People reachable through ECOWAS trade agreements, the Economic Community of West African States.
Through the ECOWAS Trade Liberalisation Scheme (ETLS), Nigeria benefits from trade agreements that eliminate customs duties on intra-regional trade. NASENI-TROMENT is positioned to serve as the primary diagnostic supplier for all 15 ECOWAS member states.
A factory that builds
more than test kits.
Jobs & Human Capital
The facility creates over 200 direct jobs spanning scientists, laboratory technicians, quality control engineers, production supervisors, and logistics and HR professionals, with thousands more indirect jobs generated across the supply chain, packaging, and distribution sectors.
The Training Centre continuously builds Nigeria's biotech workforce, creating a talent pipeline that extends beyond NASENI-TROMENT into the broader healthcare manufacturing sector.
Foreign Exchange Savings
Nigeria currently spends millions of dollars per year importing rapid diagnostic test kits. Local production eliminates this foreign exchange outflow, saving Nigeria's forex reserves and reducing dependence on international supply chains.
As exports scale to ECOWAS and global markets, the facility becomes a net foreign exchange earner, reversing the historical dynamic entirely.
Industrial Ecosystem Growth
The factory creates demand for local suppliers of plastics, packaging materials, chemical reagents, and engineering services, stimulating growth across multiple industrial sectors and contributing to Nigeria's broader manufacturing GDP.
As the facility scales, it becomes an anchor for a broader life sciences industrial cluster in Abuja, attracting related businesses and international investment.
Contributing to the goals
the world agreed on together.
NASENI-TROMENT Biotechnologies directly supports the United Nations Sustainable Development Goal 3, Good Health and Well-Being, through a homegrown biotechnology strategy that makes diagnostics for the world's most critical diseases affordable, accessible, and locally available.
Combat Malaria, HIV/AIDS, Tuberculosis, Cholera, Hepatitis, COVID-19, and other communicable diseases by 2030 through accessible diagnostic infrastructure.
200+ direct jobs. Thousands indirect. Skills development through the Training Centre. Building Nigeria's biotech workforce for a generation.
Full technology transfer and local manufacturing of medical devices represents exactly the kind of industrial innovation and infrastructure investment SDG 9 calls for in developing economies.
The NASENI-TROMENT partnership brings together federal government, private sector, and a European technology partner in a model public-private collaboration that embodies SDG 17's vision of multi-stakeholder collaboration for development.
Aligned with the administration of President Bola Ahmed Tinubu.
NASENI-TROMENT Biotechnologies is directly aligned with the industrialisation agenda of the Tinubu administration and the Nigeria First policy, which places local manufacturing, job creation, and technological independence at the centre of national economic strategy.
This factory is not just a healthcare facility. It is evidence that Nigeria can manufacture, that Nigeria can own intellectual property, that Nigeria can compete with the world on its own terms. All products manufactured here are 100% produced in Nigeria, a direct contribution to the country's strategy of building domestic capacity and reducing reliance on imported technology.
Building responsibly.
For a greener Nigeria.
Advanced biotech manufacturing processes minimise toxic waste and ensure sustainable use of resources. Our packaging strategy uses biodegradable materials to reduce plastic waste and promote a cleaner Nigeria.
Eco-Friendly Production
Advanced biotech processes minimise toxic waste at every stage of production. Wastewater treatment and materials recovery are built into facility design.
Biodegradable Packaging
N-CheckUp kits use environmentally considerate packaging materials designed to reduce plastic waste and promote circular economy principles.
Local Supply Chain
Local sourcing of plastics, packaging, and materials dramatically reduces the carbon footprint of international shipping compared to imported diagnostic kits.